Skip to main content
SpringerLink
Log in

NICE draft guidance on 5 drugs for recurrent ovarian cancer

  • Media release
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • NICE. NICE consults on ovarian cancer treatments draft guidance. Media Release : 24 Nov 2015. Available from: URL: http://www.nice.org.uk

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

NICE draft guidance on 5 drugs for recurrent ovarian cancer. PharmacoEcon Outcomes News 742, 34 (2015). https://doi.org/10.1007/s40274-015-2662-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-015-2662-0

Search

Navigation